Initial validation: early sample confirms our approach can improve patients' lives

First-round patient and clinician feedback confirms that continuous, home-based ICP monitoring addresses a real and unmet need.

As a first step, we ran a structured validation round with hydrocephalus patients, families, and treating neurosurgeons across several centres.

The signal was unambiguous: today's episodic, hospital-only ICP measurement leaves long stretches of uncertainty between visits — and both patients and clinicians see continuous, home-based monitoring as a meaningful improvement in quality of life and clinical safety.

This early evidence anchors our product roadmap in a real, unmet clinical need and confirms that the ICP Monitor is solving the right problem.